April 26, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 120,304 shares of Abrdn Life Sciences Investors at $13.00 per share, a transaction worth $1.56M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.